{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:50:29Z","timestamp":1775123429786,"version":"3.50.1"},"reference-count":28,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,4,15]]},"DOI":"10.2169\/internalmedicine.5850-20","type":"journal-article","created":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T22:09:18Z","timestamp":1605478158000},"page":"1303-1309","source":"Crossref","is-referenced-by-count":9,"title":["Complete Resolution of a Case of TAFRO Syndrome Accompanied by Mediastinal Panniculitis, Adrenal Lesion, and Liver Damage with Hyperbilirubinemia"],"prefix":"10.2169","volume":"60","author":[{"given":"Shiro","family":"Ono","sequence":"first","affiliation":[{"name":"Department of General Medicine, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyomi","family":"Yoshimoto","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobushiro","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Yoneima","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadanao","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Tai","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiko","family":"Tsushima","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noritaka","family":"Yada","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Nishio","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Nara Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Takai K, Nikkuni K, Shibuya H, Hashidate H. Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki (Jpn J Clin Hematol) 51: 320-325, 2010 (in Japanese, Abstract in English)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ito S, Uchida T, Itai H, et al. Serial manifestation of acute kidney injury and nephrotic syndrome in a patient with TAFRO syndrome. Intern Med 57: 3129-3133, 2018.","DOI":"10.2169\/internalmedicine.0806-18"},{"key":"3","unstructured":"3. Edahiro Y, Ichikawa K, Sunami Y, Koike M, Komatsu N. Autoimmune hemolytic anemia in a patient with TAFRO syndrome. Rinsho Ketsueki (Jpn J Clin Hematol) 56: 2346-2350, 2015 (in Japanese, Abstract in English)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Suzuki K, Matsumoto T, Iwashita Y, et al. Clinicopathological features of TAFRO syndrome complicated by acquired hemophilia A and development of cardiopulmonary arrest that were successfully treated with VA-ECMO and tocilizumab. Int J Hematol 109: 737-743, 2019.","DOI":"10.1007\/s12185-019-02604-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Koduri PR, Parvez M, Kaza S, Pappu P, Anuradha S. Castleman-Kojima disease in a South Asian adolescent. J Clin Exp Hematop 54: 163-166, 2014.","DOI":"10.3960\/jslrt.54.163"},{"key":"6","unstructured":"6. Nagai Y, Ando S, Honda N, et al. TAFRO syndrome showing cholangitis on liver biopsy. Rinsho Ketsueki (Jpn J Clin Hematol) 57: 2490-2495, 2016 (in Japanese, Abstract in English)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Iwaki N, Fajgenbaum DC, Nabel CS, et al. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol 911: 220-226, 2016.","DOI":"10.1002\/ajh.24242"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fujimoto S, Sakai T, Kawabata H, et al. Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease? Am J Hematol 94: 975-983, 2019.","DOI":"10.1002\/ajh.25554"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nagano M, Matsumoto J. A case of TAFRO syndrome with a large mediastinal mass treated with debulking surgery. Surg Case Reports 2: 61, 2016.","DOI":"10.1186\/s40792-016-0188-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sakashita K, Murata K, Inagaki Y, Oota S, Takamori M. An anterior mediastinal lesion in TAFRO syndrome showing complete remission after glucocorticoid and tocilizumab therapy. Respirol Case Reports 4: 5-7, 2016.","DOI":"10.1002\/rcr2.173"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Kligerman SJ, Auerbach A, Franks TJ, Galvin JR. Castleman disease of the thorax: clinical, radiologic, and pathologic correlation. Radiographics 36: 1309-1332, 2016.","DOI":"10.1148\/rg.2016160076"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Meguri Y, Asada N, Nakasako Y, et al. A case report of TAFRO syndrome successfully treated by immunosuppressive therapies with plasma exchange. Ann Hematol 98: 537-539, 2019.","DOI":"10.1007\/s00277-018-3456-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ozawa Y, Yamamoto H, Yasuo M, Takahashi H, Tateishi K, Ushiki A. Two patients with TAFRO syndrome exhibiting strikingly similar anterior mediastinal lesions with predominantly fat attenuation on chest computed tomography. Respir Investig 55: 176-180, 2017.","DOI":"10.1016\/j.resinv.2016.10.003"},{"key":"14","unstructured":"14. Coutier F, Meaux Ruault N, Crepin T, et al. A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review. Ann Hematol 97: 401-407, 2018."},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Fajgenbaum DC. Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease. Blood 132: 2323-2330, 2018.","DOI":"10.1182\/blood-2018-05-848671"},{"key":"16","unstructured":"16. Fujiwara Y, Ito K, Takamura A, Nagata K. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report. J Med Case Rep 12: 295, 2018."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Nara M, Komatsuda A, Itoh F, et al. Two cases of thrombocytopenia, anasarca, fever, reticulin fibrosis \/ renal failure, and organomegaly (TAFRO) syndrome with high serum procalcitonin levels, including the first case complicated with adrenal hemorrhaging. Intern Med 56: 1247-1252, 2017.","DOI":"10.2169\/internalmedicine.56.7991"},{"key":"18","unstructured":"18. Hong SB, Lee NK, Kim S, et al. Adrenal Castleman's disease mimicking other adrenal neoplasms: a case report. J Korean Soc Radiol 76: 73, 2017."},{"key":"19","unstructured":"19. Zheng X, Pan K, Cheng J, Dong L, Yang K, Wu E. Localized Castleman disease in retroperitoneum: newly discovered features by multi-detector helical CT. Abdom Imaging 33: 489-492, 2008."},{"key":"20","unstructured":"20. Kawabata H, Takai K, Kojima M, et al. Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: a status. J Clin Exp Hematop 53: 57-61, 2013."},{"key":"21","unstructured":"21. Ohkubo A, Kurashima N, Yamamoto H, et al. A case report: removal efficiency of bilirubin during selective plasma exchange (SePE) in TAFRO syndrome. Nihon Kyusei Ketsueki Joka Gakkai zasshi (Journal of Japan Society for Blood Purification in Critical Care) 9: 125-128, 2018 (in Japanese, Abstract in English)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kubokawa I, Yachie A, Hayakawa A, et al. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease. BMC Pediatr 14: 1-8, 2014.","DOI":"10.1186\/1471-2431-14-139"},{"key":"23","unstructured":"23. Kawashima M, Usui T, Okada H, et al. TAFRO syndrome: 2 cases and review of the literature. Mod Rheumatol 27: 1093-1097, 2017."},{"key":"24","unstructured":"24. Takai K, Nikkuni K, Momoi A, Nagai K, Igarashi N, Saeki T. Thrombocytopenia with reticulin fibrosis accompanied by fever, anasarca and hepatosplenomegaly: a clinical report of five cases. J Clin Exp Hematop 53: 63-68, 2013."},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Fajgenbaum DC, Van Rhee F, Nabel CS. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood 123: 2924-2933, 2014.","DOI":"10.1182\/blood-2013-12-545087"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tanaka M, Tsujimoto H, Yamamoto K, Shimoda S, Oka K, Takeoka H. Clinicopathological features of progressiverenal involvement in TAFRO syndrome. A case report and literature review. Medicine (Baltimore) 96: e8216, 2017.","DOI":"10.1097\/MD.0000000000008216"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kawabata H, Kotani S, Matsumura Y, et al. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody. Intern Med 52: 1503-1507, 2013.","DOI":"10.2169\/internalmedicine.52.9482"},{"key":"28","unstructured":"28. Masaki Y, Kawabata H, Takai K, et al. 2019 updated diagnostic criteria and disease severity classification for TAFRO syndrome. Int J Hematol 111: 155-158, 2020."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/8\/60_5850-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T03:59:39Z","timestamp":1618631979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/8\/60_5850-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5850-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]}}}